Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;46(4):481-9.
doi: 10.4070/kcj.2016.46.4.481. Epub 2016 Jul 21.

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention

Jinhee Ahn  1 , Seo Kwang Park  1 , Tae Sik Park  1 , Jin Hee Kim  2 , Eunyoung Yun  3 , Sang-Pil Kim  4 , Hye Won Lee  1 , Jun-Hyok Oh  1 , Jung Hyun Choi  1 , Kwang Soo Cha  1 , Taek Jong Hong  1 , Sang Yeoup Lee  5 , Han Cheol Lee  1
Affiliations

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention

Jinhee Ahn et al. Korean Circ J. 2016 Jul.

Abstract

Background and objectives: Statins remain the mainstay of secondary coronary artery disease (CAD) prevention, but n-3 polyunsaturated fatty acids (ω-3 PUFA) display biological effects that may also reduce the risk of atherosclerosis and CAD. However, data on the possible antiatherosclerotic benefits of adding ω-3 PUFA to statin therapy are limited. This study aimed to investigate the potential additive effects of ω-3 PUFA on regression of atherosclerosis in CAD patients receiving statin therapy and stent implantation.

Subjects and methods: Seventy-four CAD patients undergoing percutaneous coronary intervention (PCI) with stent implantation were enrolled, prescribed statins, and randomly assigned to two groups: n-3 group (ω-3 PUFA 3 g/day, n=38) or placebo group (placebo, n=36). All patients completed the study follow-up consisting of an intravascular ultrasound at baseline and at 12 months.

Results: There was no difference in the baseline characteristics and distribution of other medications. No significant differences were observed in primary endpoints, including changes in atheroma volume index (-12.65% vs. -8.51%, p=0.768) and percent atheroma volume (-4.36% vs. -9.98%, p=0.526), and in secondary endpoints including a change in neointimal volume index (7.84 vs. 4.94 mm(3)/mm, p=0.087).

Conclusion: ω-3 PUFA had no definite additional effect on the regression of coronary atherosclerosis when added to statin in CAD patients undergoing PCI.

Keywords: Atherosclerosis; Coronary artery disease; Statin; n-3 polyunsaturated fatty acids.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Fig. 1
Fig. 1. Intravascular ultrasound image for measurement of total atheroma volume. A cross sectional image of stenosed vessel (white circle) is shown in the inner picture. Total atheroma volume was calculated as a sum of the differences between vessel and lumen area throughout the lesion by Simpson's method.
Fig. 2
Fig. 2. Changes in lipid profiles from baseline. There were no significant reductions in levels of total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and triglyceride betwen patients with or without omega-3 polyunsaturated fatty acids.
See this image and copyright information in PMC

References

    1. Kris-Etherton PM, Harris WS, Appel LJ American Heart Association; Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757. - PubMed
    1. Cawood AL, Ding R, Napper FL, et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010;212:252–259. - PubMed
    1. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047–2067. - PubMed
    1. Amano T, Matsubara T, Uetani T, et al. Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study. Atherosclerosis. 2011;218:110–116. - PubMed
    1. Nozue T, Yamamoto S, Tohyama S, et al. A predictor of atheroma progression in patients achieving very low levels of low-density lipoprotein cholesterol. Am J Cardiovasc Dis. 2013;3:255–263. - PMC - PubMed